Targeted markets ViOptix specializes in tissue oxygenation with applications in plastic surgery, intraoperative monitoring, wound healing potential, peripheral vascular disease, and critical care, indicating multiple high-value clinical segments to target with direct outreach and bundled offerings.

Small but scalable With 11-50 employees and revenue between 1M-10M, ViOptix presents a scalable opportunity for partnerships or channel sales that can be integrated with existing distributors or OEM collaborations to accelerate market reach.

Real-time advantage The proprietary T.Ox tissue oximetry tech enables real-time, non-invasive tissue oxygen measurements, a compelling value proposition to hospitals and surgical centers seeking immediate viability assessment and improved patient outcomes.

Funding signals Current funding of 2.8M alongside modest revenue suggests room for sales of upgraded hardware, maintenance contracts, and analytics services to grow ARR through repeatable services and software-enabled features.

Competitive positioning Operating in a space with larger players like Masimo and Medtronic, ViOptix can pursue niche opportunities in plastic surgery and Vascular Critical Care where personalized support and fast ROI can differentiate the offering.